SEC Form 4 · accession 0002022345-26-000002
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Barry
Officer — EVP, President, LSG
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 5:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Sep 1, 2026 | M | 425 | $0.00 | A | 935 | D | |
| Bio-Rad A Common Stock | Sep 1, 2026 | F | 154 | $380.96 | D | 781 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Sep 1, 2026 | M | 174 | D | — | — | Bio-Rad A Common Stock | 174 | 0 | D |
| Restricted Stock UnitsF2,F4 | $0.00 | Sep 1, 2026 | M | 251 | D | — | — | Bio-Rad A Common Stock | 251 | 251 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F4On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.